芪苈强心胶囊治疗慢性心功能不全的临床效果观察(3)
[3] Shao MJ，Wang SR，Zhao MJ，et al.The effects of velvet antler of deer on cardiac functions of rats with heart failure following myocardial infarction[J].Evid Based Complement Alternat Med，2012，2012：825056.
[4] 中华医学会心血管病学分会，中华心血管病杂志编辑委员会.中国心力衰竭诊断和治疗指南2014[J].中华心血管病杂志，2014，42(2)：98-122.
[5] McMurray JJ，Adamopoulos S，Anker SD，et al.ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012：The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology.Developed in collaboration with the Heart Failure Association (HFA) of the ESC[J].Eur J Heart Fail，2012，14(8)：803-869.
[6] Bettencourt P，Azevedo A，Pimenta J，et al.N-terminal-pro-brain natriuretic peptide predicts outcome after hospital discharge in heart failure patients[J].Circulation，2004，110(15)：2168-2174.
[7] Zou Y，Lin L，Ye Y，et al.Qiliqiangxin inhibits the development of cardiac hypertrophy，remodeling，and dysfunction during 4 weeks of pressure overload in mice[J].J Cardiovasc Pharmacol，2012，59(3)：268-280.
[8] Xiao H，Song Y，Li Y，et al.Qiliqiangxin regulates the balance between tumor necrosis factor-α and interleukin-10 and improves cardiac function in rats with myocardial infarction[J].Cell Immunol，2009，260(1)：51-55.
[9] 李佳彧，杨萍.芪苈强心胶囊对心梗后心力衰竭大鼠periostin蛋白表达干预作用的研究[J].中国实验诊断学，2009，13(2)：170-172.
[10] 柴松波，王硕仁，姚立芳，等.参松养心胶囊对大鼠心梗后心肌重构和室颤阈值影响的研究[J].中国中药杂志，2009，34(16)：2101-2104.
[11] 林锐波.芪苈强心胶囊对心梗后心衰大鼠心功能及凋亡蛋白caspase-3表达的影响[D].汕头：汕头大学，2010.
[12] 柴松波，王硕仁，姚立芳，等.参松养心胶囊对大鼠心梗后心室重构及其离体心脏动作电位影响的研究[J].北京中医药，2009，28(12)：967-971.
[13] Hunt PJ，Richards AM，Nicholls MG，et al.Immunoreactive amino-terminal pro-brain natriuretic peptide (NT-PROBNP)：a new marker of cardiac impairment[J].Clin Endocrinol (Oxf)，1997，47(3)：287-296.
[14] Hobbs FD，Davis RC，Roalfe AK，et al.Reliability of N-terminal pro-brain natriuretic peptide assay in diagnosis of heart failure：cohort study in representative and high risk community populations[J].BMJ，2002，324(7352)：1498.
[15] Hartmann F，Packer M，Coats AJS，et al.Prognostic impact of plasma N-terminal pro-brain natriuretic peptide in severe chronic congestive heart failure a substudy of the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) trial[J].Circulation，2004，110(13)：1780-1786.
(收稿日期：2014-11-10 本文编辑：郭静娟) (翟娜等)
[4] 中华医学会心血管病学分会，中华心血管病杂志编辑委员会.中国心力衰竭诊断和治疗指南2014[J].中华心血管病杂志，2014，42(2)：98-122.
[5] McMurray JJ，Adamopoulos S，Anker SD，et al.ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012：The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology.Developed in collaboration with the Heart Failure Association (HFA) of the ESC[J].Eur J Heart Fail，2012，14(8)：803-869.
[6] Bettencourt P，Azevedo A，Pimenta J，et al.N-terminal-pro-brain natriuretic peptide predicts outcome after hospital discharge in heart failure patients[J].Circulation，2004，110(15)：2168-2174.
[7] Zou Y，Lin L，Ye Y，et al.Qiliqiangxin inhibits the development of cardiac hypertrophy，remodeling，and dysfunction during 4 weeks of pressure overload in mice[J].J Cardiovasc Pharmacol，2012，59(3)：268-280.
[8] Xiao H，Song Y，Li Y，et al.Qiliqiangxin regulates the balance between tumor necrosis factor-α and interleukin-10 and improves cardiac function in rats with myocardial infarction[J].Cell Immunol，2009，260(1)：51-55.
[9] 李佳彧，杨萍.芪苈强心胶囊对心梗后心力衰竭大鼠periostin蛋白表达干预作用的研究[J].中国实验诊断学，2009，13(2)：170-172.
[10] 柴松波，王硕仁，姚立芳，等.参松养心胶囊对大鼠心梗后心肌重构和室颤阈值影响的研究[J].中国中药杂志，2009，34(16)：2101-2104.
[11] 林锐波.芪苈强心胶囊对心梗后心衰大鼠心功能及凋亡蛋白caspase-3表达的影响[D].汕头：汕头大学，2010.
[12] 柴松波，王硕仁，姚立芳，等.参松养心胶囊对大鼠心梗后心室重构及其离体心脏动作电位影响的研究[J].北京中医药，2009，28(12)：967-971.
[13] Hunt PJ，Richards AM，Nicholls MG，et al.Immunoreactive amino-terminal pro-brain natriuretic peptide (NT-PROBNP)：a new marker of cardiac impairment[J].Clin Endocrinol (Oxf)，1997，47(3)：287-296.
[14] Hobbs FD，Davis RC，Roalfe AK，et al.Reliability of N-terminal pro-brain natriuretic peptide assay in diagnosis of heart failure：cohort study in representative and high risk community populations[J].BMJ，2002，324(7352)：1498.
[15] Hartmann F，Packer M，Coats AJS，et al.Prognostic impact of plasma N-terminal pro-brain natriuretic peptide in severe chronic congestive heart failure a substudy of the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) trial[J].Circulation，2004，110(13)：1780-1786.
(收稿日期：2014-11-10 本文编辑：郭静娟) (翟娜等)